Kerry LaPlante

Kerry LaPlante

University of Rhode Island

H-index: 41

North America-United States

About Kerry LaPlante

Kerry LaPlante, With an exceptional h-index of 41 and a recent h-index of 30 (since 2020), a distinguished researcher at University of Rhode Island, specializes in the field of Biofilms, pharmacodynamics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Efficacy and Practical Implementation of Fecal Microbiota Spores, Live-BRPK: A Novel Approach for Preventing Recurrent Clostridioides difficile Infection

Exploring variations in recommended first‐choice therapy for complicated urinary tract infections in males: Insights from outpatient settings across age, race, and ethnicity

Antibiotics on Demand: Advances in Asynchronous Telemedicine Call for Increased Antibiotic Surveillance

Real-world utilization of ceftazidime/avibactam among inpatients in the national Veterans Affairs Healthcare System

Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile …

Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System

Staphylococcal biofilm: penetration and bioavailability of vancomycin with or without rifampin

Real-world outcomes associated with letermovir use for cytomegalovirus primary prophylaxis in allogeneic hematopoietic cell transplant recipients: a systematic review and meta …

Kerry LaPlante Information

University

Position

___

Citations(all)

6318

Citations(since 2020)

3652

Cited By

3985

hIndex(all)

41

hIndex(since 2020)

30

i10Index(all)

95

i10Index(since 2020)

76

Email

University Profile Page

University of Rhode Island

Google Scholar

View Google Scholar Profile

Kerry LaPlante Skills & Research Interests

Biofilms

pharmacodynamics

Top articles of Kerry LaPlante

Title

Journal

Author(s)

Publication Date

Efficacy and Practical Implementation of Fecal Microbiota Spores, Live-BRPK: A Novel Approach for Preventing Recurrent Clostridioides difficile Infection

Official journal of the American College of Gastroenterology| ACG

Paul Feuerstadt

Kerry L LaPlante

2024/1/1

Exploring variations in recommended first‐choice therapy for complicated urinary tract infections in males: Insights from outpatient settings across age, race, and ethnicity

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Kathryn Sine

Thomas Lavoie

Aisling R Caffrey

Vrishali V Lopes

David Dosa

...

2024/4

Antibiotics on Demand: Advances in Asynchronous Telemedicine Call for Increased Antibiotic Surveillance

Rebecca O’Toole

Kathryn A Martinez

Michael B Rothberg

Gillian Diiorio

Edward A Stenehjem

...

2024/2/15

Real-world utilization of ceftazidime/avibactam among inpatients in the national Veterans Affairs Healthcare System

American Journal of Health-System Pharmacy

Aisling R Caffrey

Haley J Appaneal

Vrishali V Lopes

Todd A Riccobene

Kerry L LaPlante

2024/2/14

Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile …

Infectious Diseases and Therapy

Paul Feuerstadt

Jessica R Allegretti

Erik R Dubberke

Amy Guo

Adam Harvey

...

2024/1

Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System

Infectious Diseases and Therapy

Haley J Appaneal

Kerry L LaPlante

Vrishali V Lopes

Catherine Martin

Laura Puzniak

...

2024/1

Staphylococcal biofilm: penetration and bioavailability of vancomycin with or without rifampin

Diagnostic Microbiology and Infectious Disease

Kathryn E Daffinee

Emily T O'Neill

Callan R Bleick

Geoff Williams

Valentin Antoci

...

2023/7/1

Real-world outcomes associated with letermovir use for cytomegalovirus primary prophylaxis in allogeneic hematopoietic cell transplant recipients: a systematic review and meta …

Ami Vyas

Amit D Raval

Shweta Kamat

Kerry LaPlante

Yuexin Tang

...

2023/1/1

Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention

Clinical Infectious Diseases

Thomas Lavoie

Haley J Appaneal

Kerry L LaPlante

2023/12/1

Eradication of Staphylococcus epidermidis within biofilms: comparison of systemic versus supratherapeutic concentrations of antibiotics

Antimicrobial Agents and Chemotherapy

KE Daffinee

EC Piehl

C Bleick

KL LaPlante

2023/6/15

Treatment, clinical outcomes, and predictors of mortality among a national cohort of hospitalized patients with Stenotrophomonas maltophilia infection

Public Health

HJ Appaneal

VV Lopes

KL LaPlante

AR Caffrey

2023/1/1

2550. Comparing Efficacy of Serum and Epithelial Lining Fluid Concentrations for Meropenem Against Carbapenem-Resistant Enterobacterales

Open Forum Infectious Diseases

Thomas Lavoie

Katie Daffinee

jason M Pogue

Brahim Achour

Kerry L LaPlante

2023/12

Penicillin-Binding Proteins and Alternative Dual-Beta-Lactam Combinations for Serious Enterococcus faecalis Infections with Elevated Penicillin MICs

Antimicrobial Agents and Chemotherapy

Jaclyn A Cusumano

Kathryn E Daffinee

Paul Ugalde-Silva

Wolfgang Peti

Michel Arthur

...

2023/2/16

Decreasing antibiotic resistance trends nationally in gram-negative bacteria across United States Veterans Affairs Medical Centers, 2011–2020

Infectious Diseases and Therapy

J Xin Liao

Haley J Appaneal

Anupama Menon

Vrishali Lopes

Kerry L LaPlante

...

2023/7

Real-world safety and effectiveness of remdesivir and corticosteroids in hospitalized patients with COVID-19

Covid

Aisling R Caffrey

J Xin Liao

Vrishali V Lopes

Kerry L LaPlante

Haley J Appaneal

2023/2

Student pharmacists delivering academic detailing on adult pneumococcal vaccination to community pharmacists

Journal of the American Pharmacists Association

Haley J Appaneal

Krysia Lesniak

Kerry L LaPlante

Brett Feret

2023/7/1

Antibiotic Prescribing in Outpatient Settings: Rural Patients Are More Likely to Receive Fluoroquinolones and Longer Antibiotic Courses

Antibiotics

Haley J Appaneal

Aisling R Caffrey

Vrishali Lopes

David Dosa

Kerry L LaPlante

2023/1/20

Impact of clopidogrel on clinical outcomes in patients with Staphylococcus aureus bacteremia: a national retrospective cohort study

Antimicrobial Agents and Chemotherapy

Aisling R Caffrey

Haley J Appaneal

Kerry L LaPlante

Vrishali V Lopes

Erlinda R Ulloa

...

2022/6/21

Meropenem plus Ceftaroline Is Active against Enterococcus faecalis in an In Vitro Pharmacodynamic Model Using Humanized Dosing Simulations

Antimicrobial Agents and Chemotherapy

Jaclyn A Cusumano

Kathryn E Daffinee

Emily C Piehl

Mónica García-Solache

Charlene Desbonnet

...

2022/10/18

671. Relevance of Levofloxacin-Resistant MRSA and hVISA when utilizing directed antibiotic locks to treat stage 4 biofilm bone and joint infections

Open Forum Infectious Diseases

Martie Vicent

Kathryn E Daffinee

Kathryn E Daffinee

Kathryn E Daffinee

Kathryn E Daffinee

...

2022/12/1

See List of Professors in Kerry LaPlante University(University of Rhode Island)

Co-Authors

H-index: 129
Michael Givskov

Michael Givskov

Københavns Universitet

H-index: 114
David Andes

David Andes

University of Wisconsin-Madison

H-index: 95
Michael J. Rybak, Pharm.D., M.P.H., Ph.D.

Michael J. Rybak, Pharm.D., M.P.H., Ph.D.

Wayne State University

H-index: 79
Navindra Seeram

Navindra Seeram

University of Rhode Island

H-index: 64
Dr. Leonard Mermel

Dr. Leonard Mermel

Brown University

H-index: 39
Susan L. Davis

Susan L. Davis

Wayne State University

academic-engine